Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency | Zendy

Fahad Faqihi | Zendy; Abdulrahman Alharthy | Zendy; Pattarin Pirompanich | Zendy; Alfateh Noor | Zendy; Ahmad Shahzad | Zendy; Nasir Nasim | Zendy; Abdullah Balhamar | Zendy; Ziad A. Memish | Zendy; Dimitrios Karakitsos | Zendy

Open Access

Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency

Author(s) -

Fahad Faqihi,

Abdulrahman Alharthy,

Pattarin Pirompanich,

Alfateh Noor,

Ahmad Shahzad,

Nasir Nasim,

Abdullah Balhamar,

Ziad A. Memish,

Dimitrios Karakitsos

Publication year - 2020

Publication title -

respiratory medicine case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.42

H-Index - 14

ISSN - 2213-0071

DOI - 10.1016/j.rmcr.2020.101203

Subject(s) - medicine , bronchiectasis , bordetella bronchiseptica , doxycycline , pneumonia , vitamin d deficiency , vitamin , vitamin d and neurology , intensive care medicine , pediatrics , immunology , antibiotics , lung , microbiology and biotechnology , biology , bacteria , genetics

This is the first reported case, to our knowledge, of co-infection of Bordetella bronchiseptica and SARS-CoV-2 in a young patient with underlying idiopathic bronchiectasis and vitamin D3 deficiency that was treated successfully with a combination therapeutic regime integrating doxycycline, empiric therapies for COVID-19, vitamin D supplementation, and supportive ICU care. Large prospective studies are required to investigate further the role of co-infections in COVID-19 patients with bronchiectasis. Randomized control trials should examine the putative beneficial role of vitamin D supplementation in patients with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research